Cero Therapeutics Holdings Inc (CERO)

$0.07 -0.02 (-25.87%)
Market Cap 115,000.00
Revenue (ttm) 0.00
Net Income (ttm) -8.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 7,271,200
Avg Vol 2,775,432
Day's Range N/A - N/A
Shares Out 1.21M
Stochastic %K 0%
Beta 0.41
Analysts Strong Sell
Price Target $22.50

Company Profile

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 650 407 2376
Address:
201 Haskins Way, Suite 230, South San Francisco, United States
rockysat111
rockysat111 May. 6 at 8:25 PM
$CERO from April 27th CERo Therapeutics Raises Capital via Convertible Note Financing
0 · Reply
Ceri78
Ceri78 May. 4 at 5:10 PM
$CERO this is the end…
0 · Reply
Radar76
Radar76 May. 1 at 4:08 PM
$CERO I don't know until what time then wake up.. or this a slow death ? . . . .
0 · Reply
StocktwitsAragorn
StocktwitsAragorn Apr. 29 at 8:24 PM
$CERO Share Structure Market Cap Market Cap 1,284,765 04/28/2026 Authorized Shares Unlimited 04/28/2026 Outstanding Shares 41,876,315 04/28/2026 Restricted 20,313 04/28/2026 Unrestricted 41,856,002 04/28/2026 Held at DTC 41,854,454 04/28/2026 Float Float 29,912,798 11/21/2025
0 · Reply
Gg2233444
Gg2233444 Apr. 28 at 8:56 PM
$CERO it’s the year 2030… CERO is trading at $150 a share after having a major breakthrough for cancer research. We are all retired and living our best life. Speaking this into existence.
0 · Reply
BPler
BPler Apr. 23 at 6:31 PM
$CERO The value lost on the chart is insane, Insider should put their own money into it.
0 · Reply
Ceri78
Ceri78 Apr. 21 at 7:37 PM
$CERO shareholder phagocitator $-cells
0 · Reply
Gg2233444
Gg2233444 Apr. 17 at 2:13 PM
$CERO wtf
0 · Reply
gapureau
gapureau Apr. 10 at 2:46 PM
$MOBQ 95% revenue collapse in 2025 and otherwise pretty terrible 10-K. That perfectly explains almost double in SP in past week. Gotta Love OTC stocks that don't have to worry about NASDAQ delisting. Some management choose to stay on this market allowing a profitable company to fly under the radar like $RHCO. Then there is total mismanagement (either on purpose or thru stupidity), like $ILLR, $CERO, $DMN If you're going to trade penny stocks, you really should use some of these disasters as study material to learn some of the many ways investors can be used and abused.. Multiple Reverse Splits, Below market price financing deals, etc.!!! GLTA
1 · Reply
upsell
upsell Apr. 1 at 4:50 AM
$CERO https://www.stocktitan.net/news/CERO/ce-ro-therapeutics-doses-second-patient-in-cohort-2-of-phase-1-cer-eqvmtxpfk96s.html
0 · Reply
Latest News on CERO
No data available.
rockysat111
rockysat111 May. 6 at 8:25 PM
$CERO from April 27th CERo Therapeutics Raises Capital via Convertible Note Financing
0 · Reply
Ceri78
Ceri78 May. 4 at 5:10 PM
$CERO this is the end…
0 · Reply
Radar76
Radar76 May. 1 at 4:08 PM
$CERO I don't know until what time then wake up.. or this a slow death ? . . . .
0 · Reply
StocktwitsAragorn
StocktwitsAragorn Apr. 29 at 8:24 PM
$CERO Share Structure Market Cap Market Cap 1,284,765 04/28/2026 Authorized Shares Unlimited 04/28/2026 Outstanding Shares 41,876,315 04/28/2026 Restricted 20,313 04/28/2026 Unrestricted 41,856,002 04/28/2026 Held at DTC 41,854,454 04/28/2026 Float Float 29,912,798 11/21/2025
0 · Reply
Gg2233444
Gg2233444 Apr. 28 at 8:56 PM
$CERO it’s the year 2030… CERO is trading at $150 a share after having a major breakthrough for cancer research. We are all retired and living our best life. Speaking this into existence.
0 · Reply
BPler
BPler Apr. 23 at 6:31 PM
$CERO The value lost on the chart is insane, Insider should put their own money into it.
0 · Reply
Ceri78
Ceri78 Apr. 21 at 7:37 PM
$CERO shareholder phagocitator $-cells
0 · Reply
Gg2233444
Gg2233444 Apr. 17 at 2:13 PM
$CERO wtf
0 · Reply
gapureau
gapureau Apr. 10 at 2:46 PM
$MOBQ 95% revenue collapse in 2025 and otherwise pretty terrible 10-K. That perfectly explains almost double in SP in past week. Gotta Love OTC stocks that don't have to worry about NASDAQ delisting. Some management choose to stay on this market allowing a profitable company to fly under the radar like $RHCO. Then there is total mismanagement (either on purpose or thru stupidity), like $ILLR, $CERO, $DMN If you're going to trade penny stocks, you really should use some of these disasters as study material to learn some of the many ways investors can be used and abused.. Multiple Reverse Splits, Below market price financing deals, etc.!!! GLTA
1 · Reply
upsell
upsell Apr. 1 at 4:50 AM
$CERO https://www.stocktitan.net/news/CERO/ce-ro-therapeutics-doses-second-patient-in-cohort-2-of-phase-1-cer-eqvmtxpfk96s.html
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 28 at 3:37 AM
$CERO RSI: 44.44, MACD: -0.0037 Vol: 0.00, MA20: 0.03, MA50: 0.04 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PaidPiper
PaidPiper Mar. 27 at 1:37 AM
$CERO Adaptimmune filed a 'change of address' wednesday evening. Right next door to IMCR. Deal coming soon. This isn't spam, you won't hear from me again. Godspeed.
1 · Reply
BPler
BPler Mar. 25 at 5:59 PM
$CERO "Re-establishing our listing on a major exchange remains one of our key priorities. To that end, we have engaged with an investment bank to raise capital and pursue a strategy intended to support a potential relisting on the Nasdaq Capital Market. We believe that our new partner’s institutional relationships and sector expertise align well with our goal of raising sufficient capital in a disciplined manner while attracting longer-term, knowledgeable investors who are familiar with the clinical development landscape and strategic direction. In addition, we are considering other potential paths for relisting on a national securities exchange, including potential business combinations with listed companies, which may include a reverse merger or a business combination with a special purpose acquisition company. https://cero.bio/press-release?storyId=7721558661735981"
1 · Reply
Gg2233444
Gg2233444 Mar. 18 at 6:24 PM
$CERO added 75,000
0 · Reply
Stobs16
Stobs16 Mar. 14 at 1:38 AM
$CERO Trash company
0 · Reply
Zerodegree00
Zerodegree00 Mar. 12 at 4:24 AM
$CERO
1 · Reply
Washingtonstate
Washingtonstate Mar. 11 at 6:05 PM
$CERO
0 · Reply
DrStewart86
DrStewart86 Mar. 9 at 1:30 AM
$CERO
0 · Reply
Washingtonstate
Washingtonstate Mar. 8 at 12:55 AM
$CERO I am a believer
0 · Reply
Gg2233444
Gg2233444 Mar. 5 at 3:34 PM
$CERO
1 · Reply
Ceri78
Ceri78 Feb. 26 at 1:32 PM
$CERO are them still phagocytizing investor money instead of cancer cells?
0 · Reply
DrStewart86
DrStewart86 Feb. 23 at 3:31 PM
$CERO do something jerk stonk!
0 · Reply